Stocks and Finance

Allergan

Allergan 5/8/2012

02:58 : Allergan (AGN) has received a subpoena from the Department of Health's ... - Allergan (AGN) has received a subpoena from the Department of Health's Inspector General over Lap-Band, a gastric band that helps people lose weight. The device generated $203.1M in sales last year. Post your comment!
Source : seekingalpha-com

Allergan 3/29/2012

11:56 : Allergan ([[AGN]] +0.5%) moves up after Stifel Nicolaus raises its price ... - Allergan (AGN +0.5%) moves up after Stifel Nicolaus raises its price target to $110 from $90 and reiterates a Buy ahead of its R&D day. The firm expects the company's newer products to generate tangible, sustainable growth. Post your ...
Source : seekingalpha-com

Allergan 3/28/2012

08:24 : Allergan (AGN) reports a successful Phase III trial of its treatment for ... - Allergan (AGN) reports a successful Phase III trial of its treatment for overactive bladders. The company says that based on the results it has pushed forward with applications to the FDA and EU to expand the range of patients approved ...
Source : seekingalpha-com

Allergan 1/30/2012

11:49 : Forbes Earnings Preview: Allergan - Optimism surrounds Allergan (AGN), as it gets ready to report its fourth quarter results on Thursday, February 2, 2012. Analysts are expecting the company to book a profit of $1 a share, up from 88 cents a year ago.
Source : forbes-com

Allergan 9/14/2011

08:30 : Banking on Botox no concern for Allergan CEO - Wholesale prices remained unchanged in August as a decline in energy prices offset a rise in food prices. Economists had expected a drop of 0.1%. Excluding the food and energy components, prices were up 0.1%, a slightly smaller gain than the 0.2% economists ...
Source : foxbusiness-com

Allergan 8/16/2011

12:14 : Allergan ([[AGN]] +1.3%) trades higher on a CS First Boston valuation ... - Allergan (AGN +1.3%) trades higher on a CS First Boston valuation upgrade. The firm says an improving R&D pipeline and strong postioning of its glaucoma products to compete with generic alternatives should spur margin growth in H2. Post ...
Source : seekingalpha-com

Allergan 8/12/2011

09:17 : Allergan Trades Ex-Dividend - According to DividendChannel.com, on 8/16/11, Allergan, Inc (AGN) will trade ex-dividend, for its quarterly dividend of $0.05, payable on 9/8/11. As a percentage of AGN's recent stock price of $74.14, this dividend works out to approximately ...
Source : forbes-com
actualidad Allergan -
Logo Allergan


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts